Dr Jones wrote to colleagues enclosing a copy of his conference paper and explaining his decision to present the information about possible seroconversions at the conference.
Chronology Information
Date:
Chapter/issue
Blood Products and Addressing Risk: Viral Inactivation
Key Person(s)
Dr Peter M Jones